Athira Pharma, Inc. is a late-stage biopharmaceutical company headquartered in Bothell, Washington, dedicated to the development of innovative therapies aimed at restoring neuronal health and combating neurodegenerative diseases, primarily Alzheimer's disease. The company boasts a robust pipeline of small molecule candidates strategically designed to target the underlying mechanisms of these complex conditions. With a strong commitment to addressing significant unmet medical needs, Athira Pharma is well-positioned to enhance patient quality of life and establish itself as a prominent leader in the neurology sector. Show more

Location: 18706 NORTH CREEK PARKWAY, BOTHELL, WA, UNITED STATES, 98011, Bothell, WA, 98011, USA | Website: https://www.athira.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

26.62M

52 Wk Range

$2.20 - $8.36

Previous Close

$4.79

Open

$4.85

Volume

33,478

Day Range

$4.58 - $4.92

Enterprise Value

20.14M

Cash

20.87M

Avg Qtr Burn

-4.668M

Insider Ownership

13.37%

Institutional Own.

85.52%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Fosgonimeton (ATH-1017) Details Parkinson's disease, Dementia	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ATH-1105 Details Amyotrophic lateral sclerosis	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Fosgonimeton (ATH-1017) Details Alzheimer's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.